会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 10. 发明申请
    • 4-(1-BENZOFURAN-3-YL-METHYLIDENEAMINOXY.PROPOXY))-BENZOIC ACID DERIVATIVES AND RELATED COMPOUNDS AS PAI-1 INHIBITORS FOR THE TREATMENT OF IMPAIRMENT OF THE FIBRINOLYTIC SYSTEM AND OF THROMBOSIS
    • 4-(1-苯并呋喃-3-基-L-甲氧基苯氧基氧基)) - 苯甲酸衍生物及相关化合物作为PAI-1抑制剂治疗纤维蛋白溶解系统和血栓形成的影响
    • WO2005030199A1
    • 2005-04-07
    • PCT/US2004/031361
    • 2004-09-24
    • WYETHHAVRAN, Lisa, MarieBUTERA, John, AnthonyELOKDAH, Hassan, MahmoudJENKINS, Douglas, JohnGUNDERSEN, Eric, Gould
    • HAVRAN, Lisa, MarieBUTERA, John, AnthonyELOKDAH, Hassan, MahmoudJENKINS, Douglas, JohnGUNDERSEN, Eric, Gould
    • A61K31/343
    • C07D307/81
    • The present invention relates to benzofuryl-oximes of formula (I) or a pharmaceutically acceptable salt or ester form thereof wherein R 1 is a direct bond to A, C 1 -C 4 alkylene, or -O-C 1 -C 4 alkylene; R 2 and R 3 are, independently hydrogen, halogen, C 1 -C 4 alkyl, C 1 -C 3 perfluoroalkyl, -O-C 1 -C 3 perfluoroalkyl, C 1 -C 3 alkoxy, -OH, -NH 2 , -NO 2 , -O(CH 2 ) p -aryl, -O(CH 2 ) P -heteroaryl, aryl, heteroaryl, -NH(CH 2 ) P -aryl, -NH(CH 2 ) P -heteroaryl, -NH(CO)-aryl, NH(CO)-heteroaryl, -O(CO)-aryl, O(CO)-heteroaryl, -NH(CO)-CH=CH-aryl, or -NH(CO)-CH=CH-heteroaryl; p is an integer from 0-6; R 4 is hydrogen, C 1 -C 8 alkyl, or C 3 -C 6 cycloalkyl; A is -COOH or an acid mimic; X is C 1 -C 8 alkylène, C 3 -C 6 cycloalkylene, -(CH 2 ) m O-, or -(CH 2 ) m NH-; m is an integer from 1-6; and R 5 is hydrogen, C 1 -C 8 alkyl, C 3 -C 6 alkyl, C 3 -C 6 cycloalkyl, -CH 2 -C 3 -C 6 cycloalkyl, heteroaryl, -CH 2 -heteroaryl, aryl or benzyl; R 6 and R 7 are independently, hydrogen, halogen, C 1 -C 6 alkyl, C 1 -C 6 perfluoroalkyl, -O-C 1 -C 6 perfluoroalkyl, C 1 -C 6 alkoxy, _OH, -NH 2 , -NO 2 , -O(CH 2 ) n -aryl, -O(CH 2 ) n -heteroaryl, aryl, or heteroaryl; and n is an integer from 0-6, wherein the alkyl, cycloalkyl, aryl and heteroaryl groups are each optionally substituted by one or more substituents. The present compounds are PAI-1 inhibitors for the treatment e.g of impairment of the fibrinolytic system, thrombosis or cardiovascular diseases.
    • 本发明涉及式(I)的苯并呋喃基 - 肟或其药学上可接受的盐或酯形式,其中R1是与A,C1-C4亚烷基或-O-C1-C4亚烷基的直接键合; R2和R3独立地是氢,卤素,C1-C4烷基,C1-C3全氟烷基,-O-C1-C3全氟烷基,C1-C3烷氧基,-OH,-NH2,-NO2,-O(CH2) ,-O(CH 2)p - 杂芳基,芳基,杂芳基,-NH(CH 2)P - 芳基,-NH(CH 2)P - 杂芳基,-NH(CO) - 芳基,NH(CO) CO) - 芳基,O(CO) - 杂芳基,-NH(CO)-CH = CH-芳基或-NH(CO)-CH = CH-杂芳基; p是0-6的整数; R4是氢,C1-C8烷基或C3-C6环烷基; A是-COOH或酸模拟物; X是C1-C8烷基,C3-C6亚环烷基, - (CH2)mO-或 - (CH2)mNH-; m是1-6的整数; R 5是氢,C 1 -C 8烷基,C 3 -C 6烷基,C 3 -C 6环烷基,-CH 2 -C 3 -C 6环烷基,杂芳基,-CH 2 - 杂芳基,芳基或苄基; R6和R7独立地为氢,卤素,C1-C6烷基,C1-C6全氟烷基,-O-C1-C6全氟烷基,C1-C6烷氧基,_OH,-NH2,-NO2,-O(CH2)n - 芳基, - 杂芳基, - (CH 2)n - 杂芳基,芳基或杂芳基; 且n为0-6的整数,其中烷基,环烷基,芳基和杂芳基各自任选被一个或多个取代基取代。 本发明化合物是用于治疗例如纤维蛋白溶解系统,血栓形成或心血管疾病的损伤的PAI-1抑制剂。